GlassScriptPhysician profile
Jessi Green
NPI 1972193886
$2,685.85
in general payments reported to CMS, 2019-2025
17 companies · $995 in 2025
The $995 reported for 2025 was more than what 96% of Obstetrics & Gynecology (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Obstetrics & Gynecology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $138 · 2023: $340 · 2024: $1,212 · 2025: $995.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,548.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,547.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $550.90 | 2023-2025 | |
| Novo Nordisk INC | $311.67 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Mayne Pharma Commercial LLC | $295.95 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $249.01 | 2024-2025 | Myfembree |
| Astellas Pharma US INC | $225.95 | 2023-2025 | Veozah, Myrbetriq |
| Pfizer INC. | $167.31 | 2023-2025 | |
| Exeltis, USA INC. | $150.37 | 2022-2025 | Slynd |
| Gynesonics, INC. | $148.18 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Lilly USA, LLC | $138.99 | 2024-2025 | Zepbound, Mounjaro, Emgality |
| Exact Sciences Corporation | $104.53 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $100.52 | 2022-2025 | |
| Millicent US INC | $92.31 | 2024-2025 | Intrarosa, Femlyv |
| Hologic Sales and Service, LLC | $71.72 | 2023-2024 | Novasure, Coolseal Generator, Myosure Tissue Removal Device |
| Amgen INC. | $30.51 | 2022 | |
| Organon LLC | $21.28 | 2023-2025 | Nexplanon |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $13.79 | 2023 | Gardasil 9, Vaxneuvance |
| Currax Pharmaceuticals LLC | $12.86 | 2023 | Contrave |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessi Green listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.